制药公司,包括辉瑞公司,进入远程保健,进行直接到消费者的销售,目的是降低成本,增加获得服务的机会。 Pharmaceutical companies, including Pfizer, enter telehealth for direct-to-consumer sales, aiming to lower costs and enhance access.
像辉瑞这样的制药公司 正在转向直接对消费者的销售 通过进入远程保健部门。 Pharmaceutical companies like Pfizer are shifting towards direct-to-consumer sales by entering the telehealth sector. 该战略旨在消除中介,有可能降低处方药成本,改善患者获得药物的机会。 This strategy aims to eliminate intermediaries, potentially lowering prescription drug costs and improving patient access to medications. 随着这些举措的发展,它们可以大大改变传统的药品分配模式,并对整个保健环境产生影响。 As these initiatives evolve, they could significantly alter the traditional pharmaceutical distribution model and impact the overall healthcare landscape.